Panasonic Develops Industry's First*1 IPS Liquid Crystal Panel with Contrast Ratio of over 1,000,000:1
Panasonic Liquid Crystal Display Co., Ltd., a subsidiary of Panasonic Corporation, today announced it has developed a new model of its IPS liquid crystal panel that achieves a contrast ratio of over 1,000,000:1, which is 600 times*2 that of conventional liquid crystal panels. With Panasonic's unique IPS liquid crystal technologies that feature wide viewing angles, high brightness, and high reliability, the new IPS panel has achieved a high contrast ratio of over 1,000,000:1 by integrating newly developed light-modulating cells that permit pixel-by-pixel control of backlight intensity. This achieves a faithful and high-grade video display, ranging from dazzling light to pitch-black.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161202005199/en/
Structural comparison between conventional and new liquid crystal panels (Graphic: Business Wire)
The new IPS panel is ideal for use in professional-use High Dynamic Range (HDR) monitors for broadcasting stations and video production studios. HDR displays can reproduce images that are faithful to what people see, ranging from bright light to jet-black darkness. Also, the new high-contrast panel is suitable for use such as medical monitors that require faithful video display and automotive monitors that require clear visibility without black floating.
Panasonic's new IPS Liquid Crystal Panel has the following features:
- An industry-first high contrast ratio of over 1,000,000:1, which is 600 times that of conventional products
- Capable of stable operation at a maximum brightness of 1,000 cd/m2
- Can be manufactured using existing liquid crystal panel manufacturing facilities
The new high-contrast IPS panel solves the problems inherent in conventional liquid crystal panels. Despite their track record in wide-ranging applications from B-to-C to B-to-B fields, conventional liquid crystal panels suffer black floating, white washout phenomenon, in dark parts of the display area when the backlight intensity is increased to raise brightness. When the backlight intensity is lowered to make dark parts clearer, these panels also suffer a loss in sparkle in bright parts.
High-end monitors for broadcasting, video production, medical, automotive, and other fields
Sample shipment will start in January 2017.
|*1||Among IPS liquid crystal panels within a single screen without using any backlight control technique|
|(as of November 28, 2016, based on a survey conducted by Panasonic)|
|*2||Compared with Panasonic's current products that have a contrast ratio of 1,800:1|
Industry-first high contrast ratio of over 1,000,000:1 — 600 times that of conventional products
|Conventional liquid crystal panels, with a contrast ratio of approximately 1,800:1, suffer black floating in dark parts when the backlight intensity is increased, and they suffer a loss in sparkle in bright parts when the backlight intensity is lowered.|
|Panasonic’s new high-contrast IPS panel uses newly developed light-modulating cells, which operate based on the operating principle of liquid crystals, and these cells are integrated into the display cells. As a result, it is capable of controlling the amount of backlight entering the display cells pixel by pixel, thus achieving a contrast ratio of 1,000,000:1.|
|The light-modulating cells are composed of a liquid crystal material that differs in light-transmission properties from that used in the display cells, allowing independent control of the display and light-modulating cells. This has reduced light leakage significantly, allowing finely-tuned gradation expression. Furthermore, the application of Panasonic's IPS liquid crystal technologies, developed for industrial use, has achieved a contrast of 1,000,000:1 (maximum brightness: 1,000 cd/m2, minimum brightness: 0.001 cd/m2) while maintaining features including wide viewing angles and high light-transmission efficiency.|
|Consequently, the new high-contrast IPS panel can make HDR-compatible displays for professional use at broadcasting stations and video production studios, and is suitable for uses including medical monitors and automotive monitors.|
Capable of stable operation at a maximum brightness of 1,000 cd/m 2
|The new high-contrast IPS panel achieves a maximum brightness of 1,000 cd/m2 by enhancing the transmittance of the display and light-modulating cells and adopting a high-brightness backlight. For the light-modulating cells, the company has developed a light-tolerant material that provides stable operation over a long period of time, despite exposure to intense light from the high-brightness backlight, as well as a unique cell structure.|
Can be manufactured using existing liquid crystal panel manufacturing facilities
|The new panel can be manufactured using the existing equipments for liquid crystal panel manufacturing. Panasonic Liquid Crystal Display Co., Ltd., possesses an industry-leading scale of 8.5th-generation (G8.5) production lines that are capable of manufacturing 10- to 100-inch products.|
|Ratio of the brightness of white to that of black of a display|
|||IPS (In-Plane Switching) liquid crystal|
|A liquid crystal operating mode that displays images by rotating liquid crystal molecules in a plane parallel to the substrates to change light transmittance|
|Phenomenon in which black parts appear slightly whitish when watching a display screen in a dark room environment|
|||8.5th generation (G8.5)|
|Production lines that use glass substrates of 2,500 mm x 2,200 mm|
URL for downloading product photos
"Panasonic Newsroom Global" - http://news.panasonic.com/global/press/
Panasonic Corporation is a worldwide leader in the development of diverse electronics technologies and solutions for customers in the consumer electronics, housing, automotive, enterprise solutions and device industries. Since its founding in 1918, the company has expanded globally and now operates 474 subsidiaries and 94 associated companies worldwide, recording consolidated net sales of 7.553 trillion yen for the year ended March 31, 2016. Committed to pursuing new value through innovation across divisional lines, the company uses its technologies to create a better life and a better world for its customers. To learn more about Panasonic: http://www.panasonic.com/global.
Global Communications Department
Media Promotion Office
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
OTEZLA® (Apremilast) Phase III Data Showed Significant Improvements in Patients with Active Behçet’s Disease with Oral Ulcers17.2.2018 21:00 | Pressemelding
Celgene Corporation (NASDAQ:CELG) today announced that data from the phase III RELIEF™ clinical trial of OTEZLA® (apremilast) in patients with active Behçet’s Disease with oral ulcers were presented in a late-breaking oral presentation at the 2018 American Academy of Dermatology (AAD) Annual Meeting. The results showed statistically significant reductions in oral ulcers with apremilast 30 mg twice daily (BID) versus placebo through week 12. OTEZLA (apremilast) is Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4). Behçet’s Disease is a rare, chronic, multi-system inflammatory syndrome. Oral ulcers, the most common manifestation of Behçet’s Disease, can be disabling and have a substantial effect on quality of life. This study primarily evaluated the effect of apremilast on recurring oral ulcers in patients with active Behçet’s Disease who were previously treated with at least one topical or systemic medication. “Reducing oral ulcers, which are painful and can negatively im
CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study17.2.2018 08:00 | Pressemelding
Twelve-month data from the Personalised Anti-TNF therapy in Crohn’s disease Study (PANTS) was presented at the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO). The results indicate that the clinical effectiveness, safety and immunogenicity of Celltrion Healthcare’s CT-P13 (biosimilar infliximab) in patients with Crohn’s disease (CD) is comparable to those treated with reference infliximab as well as those treated with adalimumab.1 The UK-wide, three-year prospective observational study investigated primary non-response (PNR), loss of response (LOR) and adverse drug reactions (ADR) to infliximab (reference infliximab and CT-P13) and adalimumab in 1610 CD patients. The data show comparable efficacy between CT-P13, reference infliximab and adalimumab in relation to PNR, LOR and ADR rates. In addition, at week 54, the remission rate was 39.7%, 39.0% and 32.7% for reference infliximab, CT-P13 and adalimumab treated patients, respectively.1 The PANTS study investigates
Avanti Communications HYLAS 4 Satellite Arrives in French Guiana16.2.2018 18:26 | Pressemelding
Avanti Communications Group plc (“Avanti”), a leading provider of satellite data communications services in Europe, the Middle East and Africa (“EMEA”), announces its HYLAS 4 satellite has arrived safely in French Guiana ahead of its March 2018 launch. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005586/en/ Avanti Communications HYLAS 4 Satellite Arrives in French Guiana (Photo: Business Wire) The spacecraft, built by Orbital ATK was packed and shipped at their Satellite Manufacturing Facility in Dulles, Virginia, United States and flown to French Guiana, where it was unloaded and will be taken to the Arianespace launch facilities in Kourou. HYLAS 4 uses the latest High Throughput Satellite technology, doubling Avanti's Ka-band capacity across EMEA. The latest addition to Avanti's HYLAS fleet will provide: Backhaul services for mobile network operators Wholesale broadband for ISPs Connectivity for governments (civil a
General Cable Corporation Stockholders Approve Acquisition By Prysmian Group16.2.2018 17:05 | Pressemelding
General Cable Corporation (NYSE: BGC) today announced the voting results from the Company’s special meeting of stockholders held this morning. Stockholders of General Cable approved the Company’s previously announced acquisition by Prysmian Group (BIT: PRY) for $30.00 per share in cash. A total of 38,140,754 shares, representing approximately 75.34% of the total number of shares of common stock outstanding and approximately 99% of the total votes cast, were voted in favor of the merger. Subject to regulatory approvals and other customary closing conditions, the transaction is expected to close by the third quarter of 2018. About General Cable General Cable (NYSE:BGC), with headquarters in Highland Heights, Kentucky, is a global leader in the development, design, manufacture, marketing and distribution of aluminum, copper and fiber optic wire and cable products for the energy, communications, automotive, industrial, construction and specialty segments. General Cable is one of the larges
Systemic Sclerosis World Congress:Inspirational Patient Stories Reveal the Challenging Realities of Living with Devastating Rare Disease16.2.2018 09:03 | Pressemelding
Boehringer Ingelheim today unveils a new phase of 'More Than Scleroderma: The Inside Story', and launches the new patient website www.morethanscleroderma.com. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180216005188/en/ Anna, 36, living with scleroderma (Photo: Business Wire) The global initiative highlights the importance of understanding the ‘inside story’ of each individual living with scleroderma, also known as systemic sclerosis. To coincide with the Systemic Sclerosis World Congress in Bordeaux, 15-17 February 2018, new and truly inspiring patient stories are revealed, reflecting the real-life, diverse and very moving journeys of people living with scleroderma across the world. The campaign will also be launched in the U.S. The new website www.morethanscleroderma.com features a powerful collection of photographs and video stories of people living with scleroderma across the world, revealing the life-changing impact o
Philip Morris International Recognized as a Global Top Employer for the Second Year in a Row16.2.2018 08:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today is recognized for the second year in a row as a Global Top Employer. This year’s certification from the Top Employer Institute is awarded to PMI teams in 44 countries, a testament to the company’s consistency and excellence in offering an enriching and dynamic work environment, and exceptional development opportunities for employees across the globe. PMI has been recognized by the Top Employer Institute for six consecutive years. This year, PMI was awarded with five regional certifications in Europe, the Middle East, Africa and, for the first time, in North America and Latin America. Additionally, Indonesia was the first PMI affiliate to be certified in Asia. “It is a proud moment for all of us at PMI,” said Charles Bendotti, PMI Senior Vice President, People and Culture. “Our success as a company relies on the men and women who come to work every day with a passion to achieve, and a willingness to learn, grow, and